nvax: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	34,341	-8,101
Effect of exchange rate on cash, cash equivalents, and restricted cash	7,634	6,976
Net increase (decrease) in cash, cash equivalents, and restricted cash	-261,935	-276,310
Cash and cash equivalents at beginning of period	545,292	-
Cash and cash equivalents at end of period	283,357	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	34,341	-8,101
Effect of exchange rate on cash, cash equivalents, and restricted cash	7,634	6,976
Net increase (decrease) in cash, cash equivalents, and restricted cash	-261,935	-276,310
Cash and cash equivalents at beginning of period	545,292	-
Cash and cash equivalents at end of period	283,357	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)